Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verrumal proof-of-concept trial in actinic keratosis
2006-005432-24Phase 3Completed
- Sponsor
- Hermal
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of fluorouracil + salicylic acid in actinic keratosis (AK), sponsored by Hermal. Primary endpoint: Improvement in clinical score. Started Dec 2006; status: completed.
02
Drugs
fluorouracil + salicylic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2006-005432-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005432-24.